Continues to show how strong this stock will be.
Grow a pair and announce news !
1. 8 Million in cash but with now 120m shares, looks like they have 14+million in cash with warrants exercised.
2, Burn rate including trials only 500k/month, so 28 months of money available and more cash coming.
3. We intend to identify and initiate discussions with potential partners in the next 12 months, Who else wants to make at least 100% in a year?
4. The data demonstartes SIGNIFICANT improvement in the reduction of seizues to three GENERATIONS of epilepsy drugs currently on the market as well as significant synergy with each of thes drugs. Go alone or another partnership/buyout ! ( better results than GWPH )
5 Michael J Fox grant for parkinsons
6. Patent granted for major CNS diseases for lead drug
7. Lead drug focus on Alzheimers, Parkinsons, depression, MS, multiple cancers.
The primary endpoint of the Phase 2a trial is evaluation of the maximum tolerated dose of ANAVEX 2-73, which had shown potential in preclinical studies to prevent, halt and/or reverse the course of the disease.
Will run like AQXP last 2 days.
And thx for the kind posts.
Point 2 July 15th balnce sheet 8 million was in cash so I know that is fact. Point 4 was stated by both CEO and PR firm, call them. Point 5, I agree earnigs will be due then and company always updates shareholders. 6. Dont you do any due diligence..thats well know from MS to epilepsy.
Also company presentations scheduled, warrants exercised and sold already, no overhang and UPLISTING coming.